Pricing Log in Create free account

Notable Labs, Ltd. (NTBLQ) vs Valion Bio, Inc. (VBIO)

Notable Labs, Ltd. and Valion Bio, Inc. are both Biotechnology companies. Notable Labs, Ltd. and Valion Bio, Inc. are of similar size ($2.4M and $2.4M). Valion Bio, Inc. grew revenue faster over the last twelve months: −49.6% against −129.0%. Notable Labs, Ltd. has the higher net margin (6,350.6% vs 0.00%) and the lower return on invested capital (−295.4% vs −61.0%). Across the 16 metrics below, Notable Labs, Ltd. leads on 11 and Valion Bio, Inc. on 5.

Valuation

Metric NTBLQ VBIO Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.33 9.71
P/B n/m 0.04 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.25 n/m 0.64
EV/Sales 23.30 11.28 9.21
Earnings yield 0.00% (15,509.47%) (33.15%)
Free cash flow yield 0.00% (9,619.81%) (25.50%)

Profitability

Metric NTBLQ VBIO Biotechnology median
Gross margin 116.87% (58.09%) 65.16%
Operating margin 9,259.04% 0.00% 0.00%
Net margin 6,350.60% 0.00% 0.00%
Free cash flow margin 9,158.43% 0.00% 0.00%
Return on equity (79.79%) (489.30%) (56.36%)
Return on assets (59.14%) (104.96%) (48.04%)
Return on invested capital (295.36%) (61.01%) 0.00%

Growth

Metric NTBLQ VBIO Biotechnology median
Revenue growth (TTM) (129.02%) (49.63%) 6.02%
EPS growth (last fiscal year) 84.47% 60.16% 30.26%
Revenue growth, 5-year CAGR (11.93%) 13.18% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NTBLQ VBIO Biotechnology median
Debt to equity 0.03 0.62 0.00
Current ratio 2.77 1.11 4.72
Net debt to EBITDA 0.80 0.79 0.96

Dividend

Metric NTBLQ VBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NTBLQ VBIO Biotechnology median
Market cap 2.39m 2.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack